Clearasil Ultra Spot Blocker Gel Pen
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide salicylique | 2 % |
Non-medicinal ingredients
propylèneglycol, Isoceteth-20, Hydroxyde de sodium, EDTA de sodium, Allantoïne, alcool dénaturé, Menthol, Hydroxyethyl Cellulose, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
For the prevention and treatment of acne. Clears existing pimples fast. Helps stop a pimple in its tracks. Penetrates deep into the pores to effectively fight pimples at its source.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Flammable, keep away from open fire or flame. When using this product with other topical acne medications, at the same time or immediately following use of this product, increase dryness or irritation of the skin may occur. If this occurs, only one medication should be used unless directed by a doctor. Avoid contact with eyes. If contact occurs, rinse thoroughly with water. Stop use and ask a doctor if skin or eye irritation develops. In case of accidental ingestion, get medical help or contact a Poison Control Centre immediately.
Product record
- Other names
- Clearasil Ultra Pimple Blocker Gel Pen
- Licence holder
- Reckitt Benckiser (Canada) Inc.
- NPN or DIN-HM
- 80007055
- Status
- Active licence
- Licence date
- 12 August 2008
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Source
Official Health Canada record, licence 80007055
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Clearasil Ultra Spot Blocker Gel Pen (Reckitt Benckiser (Canada) Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80007055-clearasil-ultra-spot-blocker-gel-pen, updated 12 August 2008.